Wolverine Asset Management LLC Horizon Therapeutics Public LTD CO Transaction History

Wolverine Asset Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$98.98 - $115.74 $723,939 - $846,522	7,314 Added 22.45%	39,899 $4.62 Million
Q2 2023 Aug 07, 2023	SELL	$96.34 - $112.38 $176,302 - $205,655	-1,830 Reduced 5.32%	32,585 $3.35 Million
Q1 2023 May 08, 2023	BUY	$107.32 - $113.5 $1.61 Million - $1.7 Million	14,982 Added 77.1%	34,415 $3.76 Million
Q4 2022 Feb 01, 2023	BUY	$62.39 - $113.8 $1.21 Million - $2.21 Million	19,433 New	19,433 $2.21 Million
Q2 2021 Aug 13, 2021	SELL	$86.24 - $95.92 $124,444 - $138,412	-1,443 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $989,601 - $1.32 Million	-13,777 Reduced 90.52%	1,443 $132,000
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $525,481 - $661,870	7,843 Added 106.32%	15,220 $1.11 Million
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $407,431 - $589,643	7,377 New	7,377 $573,000
Q2 2020 Aug 13, 2020	SELL	$30.2 - $56.98 $31,951 - $60,284	-1,058 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$24.87 - $38.56 $35,862 - $55,603	-1,442 Reduced 57.68%	1,058 $31,000
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $34,500 - $41,955	1,500 Added 150.0%	2,500 $68,000
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $22,810 - $28,480	1,000 New	1,000 $24,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.